يعرض 1 - 10 نتائج من 97 نتيجة بحث عن '"Aldape"', وقت الاستعلام: 1.52s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المصدر: Nature Medicine. 27:1117-1120

  4. 4
  5. 5

    المساهمون: Medical psychology, CCA - Cancer Treatment and quality of life, Neurology, Jaeckle K.A., Ballman K.V., Van Den Bent M., Giannini C., Galanis E., Brown P.D., Jenkins R.B., Cairncross J.G., Wick W., Weller M., Aldape K.D., Dixon J.G., Anderson S.K., Cerhan J.H., Wefel J.S., Klein M., Grossman S.A., Schiff D., Raizer J.J., Dhermain F., Nordstrom D.G., Flynn P.J., Vogelbaum M.A.

    المصدر: Neuro-Oncology, 23(3), 457-467. Oxford University Press
    Neuro Oncol
    Jaeckle, K A, Ballman, K V, van den Bent, M, Giannini, C, Galanis, E, Brown, P D, Jenkins, R B, Cairncross, J G, Wick, W, Weller, M, Aldape, K D, Dixon, J G, Anderson, S K, Cerhan, J H, Wefel, J S, Klein, M, Grossman, S A, Schiff, D, Raizer, J J, Dhermain, F, Nordstrom, D G, Flynn, P J & Vogelbaum, M A 2021, ' CODEL : phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design ', Neuro-Oncology, vol. 23, no. 3, pp. 457-467 . https://doi.org/10.1093/neuonc/noaa168

    وصف الملف: STAMPA

  6. 6
  7. 7
  8. 8
  9. 9

    المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie, Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Service d’Oncologie Médicale [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Neurology, Pathology, CCA - Cancer Treatment and quality of life, CCA - Imaging and biomarkers

    المصدر: Lancet oncology, 22(6), 813-823. Elsevier Science
    van den Bent, M J, Tesileanu, C M S, Wick, W, Sanson, M, Brandes, A A, Clement, P M, Erridge, S, Vogelbaum, M A, Nowak, A K, Baurain, J F, Mason, W P, Wheeler, H, Chinot, O L, Gill, S, Griffin, M, Rogers, L, Taal, W, Rudà, R, Weller, M, McBain, C, Reijneveld, J, Enting, R H, Caparrotti, F, Lesimple, T, Clenton, S, Gijtenbeek, A, Lim, E, Herrlinger, U, Hau, P, Dhermain, F, de Heer, I, Aldape, K, Jenkins, R B, Dubbink, H J, Kros, J M, Wesseling, P, Nuyens, S, Golfinopoulos, V, Gorlia, T, French, P & Baumert, B G 2021, ' Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study ', The Lancet Oncology, vol. 22, no. 6, pp. 813-823 . https://doi.org/10.1016/S1470-2045(21)00090-5
    Lancet Oncology
    Lancet Oncology, 2021, 22 (6), pp.813-823. ⟨10.1016/S1470-2045(21)00090-5⟩
    The Lancet Oncology, 22(6), 813-823. Lancet Publishing Group
    The Lancet Oncology, 22(6), 813-823. ELSEVIER SCIENCE INC
    Lancet Oncology, Elsevier, 2021, 22 (6), pp.813-823. ⟨10.1016/S1470-2045(21)00090-5⟩
    Lancet Oncology, 22, 6, pp. 813-823
    Lancet Oncology, 22, 813-823

    وصف الملف: application/pdf

  10. 10